Alpha Sense BI

AUGUST 30, 2023

Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027. The time is now to invest in a market intelligence platform with AI search capabilities, so you can speed up your research and outperform the market.

Management 98

Management Biotech Due Diligence Algorithm 98

Alpha Sense BI

MAY 28, 2024

The top three trending sectors—information technology, healthcare/biotech, and business and financial services— ushered in funding rounds over $100 million since the beginning of the year. Want to learn about how AlphaSense is empowering venture capital firms to accelerate their research efforts?

Capital 69

Capital Startups Biotech Due Diligence 69

Alpha Sense BI

APRIL 29, 2024

This staggering statistic is representative of a transformative shift in the asset management space away from archaic research methods. Generative AI in venture capital streamlines workflows, reduces research and due diligence blind spots, and surfaces qualitative and quantitative insights to make data-driven decisions faster.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

APRIL 19, 2024

Spatial Computing is Poised for Growth A relatively new concept, spatial computing is defined as “human interaction with a machine in which the machine retains and manipulates referents to real objects and spaces,” according to MIT Media Lab researcher Simon Greenwold. billion by 2030 with a CAGR of 23.1%

Technology 69

Technology Technology Retail Biotech 69

Alpha Sense BI

APRIL 12, 2024

Expert interviews are a critical primary research tool that financial professionals often leverage to complete their investment process with last-mile, experiential insights. Soft Data – Investment researchers often use soft market data to add qualitative context to numerical data and create a comprehensive view of any research topic.

Primary Research 52

Primary Research Advantage Advantage Research 52

Alpha Sense BI

MAY 5, 2023

Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97

Biotech Capital Banking Startups 97

Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. while completing his postdoctoral research work with the University of California. He holds B.A.

Retail 52

Retail Capital Finance Biotech 52